Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology.

Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within […]

The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment

Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in […]